Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 7, 2006, Pages 1905-1908

  Huang, Weigang ^b   Li, Jingya ^b   Zhang, Wei ^b   Zhou, Yueyang ^b   Xie, Chuanming ^b   Luo, Yu ^b   Li, Yunfei ^b   Wang, Jingli ^a   Li, Jia ^b   Lu, Wei ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Cancer; Cdc25 phosphatases; Miltirone

Indexed keywords

ANTINEOPLASTIC AGENT; MILTIRONE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DIVISION; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; TUMOR CELL;

CDC25 PHOSPHATASE; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; PHENANTHRENES; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 33144467432     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.12.080     Document Type: Article

References (41)

1. I. Nilsson, and I. Hoffmann Prog. Cell Cycle Res. 4 2000 107
2. K. Galaktionov, and D. Beach Cell 67 1991 1181
3. K. Sadhu, S.I. Reed, H. Richardson, and P. Russell Prog. Natl. Acad. Sci. U.S.A. 87 1990 5139
4. A. Nagata, M. Igarashi, S. Jinno, K. Suto, and H. Okayama New Biol. 3 1991 959
5. H. Sasaki, H. Yukiue, Y. Kobayashi, M. Tanahashi, S. Moriyama, Y. Nakashima, I. Fukai, M. Kiriyama, Y. Yamakawa, and Y. Fujii Cancer Lett. 173 2001 187
6. M.G. Cangi, B. Gukor, P. Soung, S. Signoretti, G. Moreira Jr., M. Ranashinge, B. Cady, M. Pagano, and M. Loda J. Clin. Invest. 106 2000 753
7. I. Takemasa, H. Yamamoto, M. Sekimoto, M. Ohue, S. Noura, Y. Miyake, T. Matsumoto, T. Aihara, N. Tomita, Y. Tamaki, I. Sakita, N. Kikkawa, N. Matsuura, H. Shiozaki, and M. Monden Cancer Res. 60 2000 3043
8. S. Hernandez, X. Bessa, S. Bea, L. Hernmandez, A. Nadal, C. Mallofre, J. Muntane, A. Castells, P.L. Fernandez, A. Cardesa, and E. Campo Lab. Invest. 81 2001 465
9. K.E. Pestell, A.P. Ducruet, P. Wipf, and J.S. Lazo Oncogene 2000 6607 and the references reviewed in this paper
10. J.S. Lazo, D.C. Aslan, K.E. Pestell, K. Cooley, A.P. Ducruet, B. Joo, A. Vogt, and P. Wipf J. Med. Chem. 44 2001 4042
11. H. Peng, D.M. Otterness, R.T. Abraham, and L.H. Zalkow Tetrahedron 57 2001 1891
12. A. Loukaci, I.L. Saout, M. Samadi, S. Leclerc, E. Damiens, L. Meijer, C. Debitus, and M. Guyot Bioorg. Med. Chem. 9 2001 3049
13. M. Sodeoka, R. Sampe, S. Kojima, Y. Baba, T. Usui, K. Ueda, and H. Osada J. Med. Chem 44 2001 3216
14. N. Aligiannis, S. Mitaku, D. Mitorocotsa, and S. Leclerc Planta Med. 67 2001 468
15. J.S. Lazo, K. Nemoto, K.E. Pestell, K. Cooley, E.C. Southwick, D.A. Mitchell, W. Furey, R. Gussio, D.W. Zaharevitz, B. Joo, and P. Wipf Mol. Parmacol. 61 2002 720
16. C. Chen, Y.Z. Liu, K.S. Shia, and H.Y. Teseng Bioorg. Med. Chem. Lett. 12 2002 2729
17. P. Wipf, C.R. Hopkins, E.O. Phillips, and J.S. Lazo Tetrahedron 58 2002 6367
18. l. Pu, A.A. Amoscato, M.E. Bier, and J.S. Lazo J. Biol. Chem. 277 2002 46877
19. D. Brohm, N. Phillippe, S. Metzger, A. Bhargava, O. Muller, F. Lieb, and H. Waldmann J. Am. Chem. Soc. 124 2002 13171
20. S. Kar, I.M. Lefterov, W. Wang, J.S. Lazo, C.N. Scott, C.S. Wilcox, and B.I. Carr Biochemistry 42 2003 10490
21. J. Sohn, B. Kiburz, Z. Li, L. Deng, A. Safi, M.C. Pirrung, and J. Rudolph J. Med. Chem. 46 2003 2580
22. M.C. Brezak, M. Quaranta, O. Mondesert, M.O. Galcera, O. Lavergne, F. Alby, M. Cazales, V. Baldin, C. Thurieau, J. Harnett, C. Lanco, P. Kasprzyk, G.P. Prevost, and B. Ducommun Cancer Res. 64 2004 3320
23. S. Baurle, T. Blume, J. Gunther, D. Henschel, R.C. Hillig, M. Husemann, A. Mengel, C. Parchmann, E. Schmid, and W. Skuballa Bioorg. Med. Chem. Lett. 14 2004 1673
24. I. Erdogan-orhan, B. Sener, S.D. Rosa, J. Perez-Baz, O. Lozach, M. Leost, S. Rakhilin, and L. Meijer Nat. Prod. Res. 18 2004 1
25. A. Furstner, K. Reinecke, H. Prinz, and H. Waldmann ChemBioChem 5 2004 1575
26. M. Brisson, T. Nguyen, A. Vogt, J. Yalowich, A. Giorgianni, D. Tobi, I. Bahar, C.R.J. Stephenson, P. Wipf, and J.S. Lazo Mol. Pharmacol. 66 2004 824
27. S.W. Ham, and S. Lee Bull. Korean Chem. Soc. 25 2004 1755
28. M.O.C. Galcera, O. Lavergne, M.C. Brezak, B. Ducommun, and G. Prevost Bioorg. Med. Chem. Lett. 14 2004 5809
29. S. Cao, C. Foster, M. Brisson, J.S. Lazo, and D.G.I. Kingston Bioorg. Med. Chem. 13 2005 999
30. A. Shimbashi, A. Tsuchiya, M. Imoto, and S. Nishiyama Bioorg. Med. Chem. Lett. 15 2005 61
31. S. Cao, C. Foster, J.S. Lazo, and D.G.I. Kingston Bioorg. Med. Chem. 13 2005 5830
32. O. Lavergne, A.C. Fernandes, L. Brehu, A. Sidhu, M.C. Brezak, G. Prevost, B. Ducommum, and M.O.C. Galcera Bioorg. Med. Chem. Lett. 16 2006 171
33. M.P. Brun, E. Braud, D. Angotti, O. Mondesert, M. Quaranta, M. Montes, M. Miteva, N. Gresh, B. Ducommun, and C. Garbay Bioorg. Med. Chem. Lett. 13 2005 4871
34. S. Cao, C. Foster, J.S. Lazo, and D.G.I. Kingston Bioorg. Med. Chem. 13 2005 5094
35. W.G. Huang, Y.Y. Jiang, Q. Li, J. Li, J.Y. Li, W. Lu, and J.C. Cai Tetrahedron 61 2005 1863
36. S.Y. Ryu, C.O. Lee, and A.U. Choi Planta Med. 63 1997 339
37. T. Hayashi, H. Kakisawa, H.Y. Hsu, and Y.P. Chen J. Chem. Soc., Chem. Commun. 1970 299
38. H.M. Chang, K.P. Cheng, T.F. Choang, H.F. Chow, K.Y. Chui, P.M. Hon, F.W.L. Tan, Y. Yang, and Z.P. Zhong J. Org. Chem. 55 1990 3537
39. a,b. The typical inhibition assay for cdc25s was carried out in a 100 μL system containing 50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 2 mM DTT, 2 mM EDTA, 1% glycerol, 10 μM OMFP, 2% DMSO, and 200-300 nM GST-cdc25A or 40-80 nM GST-cdc25B. For the PTP1B assay, the reaction system was 50 mM MOPs, pH 6.5, 2 mM DTT, 1 mM EDTA, 2 mM pNPP, 2% DMSO, and 30-40 nM GST-PTP1B. S. Walchli, M.L. Curchod, R.P. Gobert, S. Arkinstall, and R.H.V. Huijsduijnen J. Biol. Chem. 275 2000 9792
40. K. Tamura, E.C. Southwick, J. Kerns, K. Rosi, B.I. Carr, C. Wilcox, and J.S. Lazo Cancer Res. 60 2000 1317
41. Inhibition of cell proliferation assay: growth inhibition of the tumor cells was analyzed by the MTT method. Human tumor cell lines HCT116 and A549 were trypsined and seeded with 3000 cells/well in 96-well plates, after attaching, cells were treated with different concentration compounds for subsequent 72 h incubation. Then, 40 μL MTT (5 mg/mL) was added into 200 μL medium each well and incubated for 3 h, finally the medium was removed and 500 μL dimethylsulfoxide was added to each well. The absorbance of each well at 550 nM (reference wave length is 690 nM) was determined using SpectraMAX340 microplate reader (Molecular Devices, Sunnyvale, CA).